MEDI-528, now recognized as enokiizumab , represents a innovative medication targeting the insulin-like growth factor 1 receptor , a crucial protein linked in several skin diseases . Early clinical https://lillibgje844039.wikitelevisions.com/9509856/enokizumab_a_deep_dive_into_medi_528_and_its_potential